BioLine Rx Ltd (FRA:YP2)
€ 2.08 -0.080 (-3.7%) Market Cap: 9.05 Mil Enterprise Value: 5.48 Mil PE Ratio: 9,999.00 PB Ratio: 0.79 GF Score: 21/100